White House to Replace FDA Leader Amid Agency Turmoil

The White House is reportedly preparing to replace FDA Commissioner Marty Makary amid agency turmoil. According to sources, President Trump has expressed dissatisfaction with Makary’s leadership and performance.

Makary has been at the helm of the FDA since 2017, overseeing various regulatory decisions, including those related to food safety, pharmaceuticals, and tobacco products. However, there have been reports of internal conflicts within the agency, which may have contributed to Trump’s decision to seek a replacement.

The White House has not commented on the specifics of Makary’s tenure or the reasons behind his potential departure. The FDA has also declined to comment on the matter.

It is worth noting that Makary has been a vocal advocate for stricter regulations on tobacco products and flavored vapes, which have been contentious issues under Trump’s administration. Some reports suggest that Trump may be seeking to replace Makary with someone who is more aligned with his views on these matters.

The news comes as the FDA is facing increased scrutiny over its handling of various public health issues, including the opioid crisis and the COVID-19 pandemic. The agency’s leadership has been under pressure to demonstrate its commitment to protecting public health.

As the situation unfolds, it remains unclear what the future holds for Makary or the FDA under his leadership.

Source: Google News World